[go: up one dir, main page]

Ogunyemi et al., 2001 - Google Patents

122 Noninvasive cutaneous cardiovascular findings and traditional cardiovascular measurements in substance abusing patients during pregnancy

Ogunyemi et al., 2001

Document ID
3417184105363450329
Author
Ogunyemi D
Cuellar F
Zadeh N
Teiichiro F
Publication year
Publication venue
American Journal of Obstetrics and Gynecology

External Links

Continue reading at scholar.google.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/43—Detecting, measuring or recording for evaluating the reproductive systems
    • A61B5/4306—Detecting, measuring or recording for evaluating the reproductive systems for evaluating the female reproductive systems, e.g. gynaecological evaluations
    • A61B5/4343—Pregnancy and labour monitoring, e.g. for labour onset detection
    • A61B5/435—Assessing cervix alteration or dilation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
    • A61B5/0402—Electrocardiography, i.e. ECG
    • A61B5/0444—Foetal cardiography
    • A61B5/0448—Electrodes specially adapted therefor, e.g. scalp electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024—Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02411—Detecting, measuring or recording pulse rate or heart rate of foetuses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
    • A61B8/0858—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving measuring tissue layers, e.g. skin, interfaces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements

Similar Documents

Publication Publication Date Title
Benacerraf et al. Sonographic detection of fetuses with trisomies 13 and 18: accuracy and limitations
Kupesic et al. Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age
Puerto et al. Ultrasonography as a predictor of embryo implantation after in vitro fertilization: a controlled study
Pollack et al. Macrosomia in postdates pregnancies: the accuracy of routine ultrasonographic screening
Oloyede et al. Uterine artery Doppler study in second trimester of pregnancy
Kopta et al. A comparison of the reliability of the estimated date of confinement predicted by crown-rump length and biparietal diameter
Yagel et al. Placental blood flow measured by simultaneous multigate spectral Doppler imaging in pregnancies complicated by placental vascular abnormalities
Brown et al. The umbilical artery pulsatility index in the first trimester: is there an association with increased nuchal translucency or chromosomal abnormality?
Bernaschek et al. Complications of cordocentesis in high‐risk pregnancies: effects on fetal loss or preterm delivery
Liberati et al. Uterine artery Doppler velocimetry in pregnant women with lateral placentas
Delisle et al. 124 Antepartum external cephalic version under spinal anesthesia: A randomized controlled trial
Pistorius et al. Trisomy 21 screening with αlpha software and the Fetal Medicine Foundation algorithm
Cheng et al. First‐trimester nuchal translucency measurement and echocardiography at 16 to 18 weeks of gestation in prenatal detection for trisomy 18
Morita et al. Potential use of bioelectrical impedance analysis in the assessment of edema in pregnancy
Ogunyemi et al. 122 Noninvasive cutaneous cardiovascular findings and traditional cardiovascular measurements in substance abusing patients during pregnancy
Barton et al. 123 Interleukin 1 receptor antagonist gene polymorphism and adverse pregnancy outcome in 207 pregnancies
Wilbourne et al. 121 Diagnosing prenatal substance use at birth: Rates of diagnosis in substance dependent women and their infants
Angelica Zoppi et al. First trimester umbilical artery pulsatility index in fetuses presenting enlarged nuchal translucency
Habek et al. Modified fetal biophysical profile in the assessment of perinatal outcome
Nakagawa et al. A reduction in intraovarian arterial blood flow resistance after ovulation is necessary to achieve pregnancy in natural cycle
Holmes et al. Prospective study of parental choice for aneuploidy screening in assisted conception versus spontaneously conceived twins
Anyaegbunam et al. A longitudinal evaluation of the efficacy of umbilical Doppler velocimetry in the diagnosis of intrauterine growth retardation
Hsu et al. Preliminary normal reference values of nuchal translucency thickness in Taiwanese fetuses at 11-14 weeks of gestation
Šumanovac et al. Biomechanics of fetal membranes–relation with newborn and maternal anthropometric data
Daniel-Spiegel et al. Umbilical-placental blood flow gradient during the early second trimester of pregnancy